Navigation Links
American Heart Association 2008 Wrap-Up Report: Top Research Advances Include Studies That Influence Medical Care, Apply Science To 'Real World' Communities
Date:1/21/2009

DALLAS, Jan. 21 /PRNewswire-USNewswire/ -- Clinical studies that may influence medical care and research that demonstrates how science can be effectively applied in the real world top the list of cardiovascular disease and stroke advances from 2008, said Timothy Gardner, M.D., president of the American Heart Association.

The American Heart Association has been compiling an annual list of the top 10 major advances in heart disease and stroke research since 1996.

"It's always difficult to choose from among such a broad array of new discoveries," Gardner said. "This year we included not only novel work in fundamental or basic science, but also important clinical studies that we believe will influence medical care in the future. In addition, we have chosen a number of studies that demonstrate the effectiveness of science applied in the real world, from hospitals to schools to whole communities. These implementation studies are of increasing importance as we try to determine how best to translate basic and clinical science for the benefit of the public."

Achievements in 2008 include:

1. Breathing cleaner air.

Smoke-free legislation and hospitalizations for acute coronary syndrome

Data regarding the dangers of first-hand smoke exposure is generally accepted, but the concept that secondhand smoke exposure can cause serious harm still meets resistance. This has made passing effective clean air legislation more difficult, though there has been substantial progress, with many states in the United States and several European countries passing smoke-free legislation. Previous studies of the effects of such legislation in individual towns and cities, while positive, have been criticized by some for lack of controls and incomplete data collection. However, a study in 2008, addressing many of these concerns, makes a very strong case for this type of public health
'/>"/>

SOURCE American Heart Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Horphag Research Receives 2008 Frost & Sullivan North American Health Ingredients Excellence In Research Award
2. African-Americans have worse prognosis at colorectal cancer diagnosis
3. The American Red Cross Honors Community Hero Dr. Martin Luther King Jr.
4. Christie Brinkley Helps Launch New Campaign to Reintroduce Americans to Milk as Natures Wellness Drink
5. Americans Continue Eating Nutritious and Convenient Snacks Despite Tough Economic Times
6. American Association for Homecare Criticizes Release of Controversial Medicare Bidding Rule in Final Hours of Bush Administration
7. More Americans Urged to Get Cancer Screenings
8. Economic Stimulus Package Could Impinge on Americans Health Privacy
9. Detroit Area Hospitals Seek $75 Million from United American HealthCare Arising out of its Management of the Liquidated OmniCare HMO
10. Survey: Americans Love for Financial Security Taking Precedence over Traditional Romance This Valentines Day
11. Video: Supermodel Kim Alexis Joins Forces with the American Association of Clinical Endocrinologists in a National PSA to Raise Awareness About Thyroid Problems
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:New Studies Support Use of Intravenous Vimpat(R) (lacosamide) (C-V) in Hospital and Emergency Settings 2Health News:New Studies Support Use of Intravenous Vimpat(R) (lacosamide) (C-V) in Hospital and Emergency Settings 3Health News:New Studies Support Use of Intravenous Vimpat(R) (lacosamide) (C-V) in Hospital and Emergency Settings 4Health News:New Studies Support Use of Intravenous Vimpat(R) (lacosamide) (C-V) in Hospital and Emergency Settings 5Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 2Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 3Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 4Health News:Top 10 Toys That Will Scar Your Child for Life 2Health News:Gene Barduson Named Chairman of PerfectServe Board of Directors 2Health News:Cubicle Curtain Factory Retains TransMedia Group to Promote First Privacy Curtain to Reduce Hospital Maintenance Cost 2